# K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

> **NCT01137331** · PHASE3 · COMPLETED · sponsor: **Moberg Pharma AB** · enrollment: 201 (actual)

## Conditions studied

- Seborrhoeic Eczema of the Scalp

## Interventions

- **DRUG:** K301
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01137331
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2010-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137331, "K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT01137331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*